نتائج البحث

تحتوي على الكلمات

فقط من النوع

A Phase III, Double-Blind, Randomised Study to Assess the Efficacy and Safety of AZD9291 versus a Standard of Care Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with Epidermal Growth Factor Receptor Mutation Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer قائمة الدراسات السريرية المسجلة على الادوية

" A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer" قائمة الدراسات السريرية المسجلة على الادوية

A randomized, double-blinded placebo-controlled, phase 3, parallel-group design study evaluating the efficacy and safety of Efgartigimod PH20 SC Administered by prefilled syringe in adults participants with ocular MG قائمة الدراسات السريرية المسجلة على الادوية

A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult participants with nonrelapsing secondary progressive multiple sclerosis. قائمة الدراسات السريرية المسجلة على الادوية

V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy قائمة الدراسات السريرية المسجلة على الادوية

A prospective, randomized, double-blind, multicenter, placebo-controlled, parallel group, adaptive Phase 3 study with open-label extension to evaluate efficacy and safety of macitentan 75 mg in inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension. قائمة الدراسات السريرية المسجلة على الادوية

An Open-Label Study in Adolescent and Adult Severe (Coagulation Factor Activity <1%) Hemophilia A or B Patients With or Without Inhibitors Comparing Standard Treatment to PF-06741086 Prophylaxis قائمة الدراسات السريرية المسجلة على الادوية

A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of VX-880 in Subjects With Type 1 Diabetes With a Kidney Transplant قائمة الدراسات السريرية المسجلة على الادوية

COPPER,MANGANESE,CYANOCOBALAMIN,THIAMINE,RIBOFLAVIN (VITAMIN B2),PYRIDOXINE (VITAMIN B6),ZINC OXIDE,PANTOTHENIC ACID,FERROUS FUMARATE,SELENIUM SULFIDE,CHROMIUM CHLORIDE HEXAHYDRATE,POTASSIUM CHLORIDE,SODIUM MOLYBDATE,ASCORBIC ACID,BIOTIN,IODINE,PHOSPHORUS,CALCIUM PHOSPHATE,FOLIC ACID,COLECALCIFEROL (VITAMIN D3),LUTEIN,BETA CAROTENE,VITAMIN K1,NICOTINAMIDE المستودعات المرجعية

An Open-label, Baseline-controlled, Multicenter, Phase 3 Dose-titration Study Followed by a Fixed-dose Observation Period to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Children and Adolescents from 5 to less than 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC) قائمة الدراسات السريرية المسجلة على الادوية